Limited coverage criteria – mometasone furoate in combination with formoterol

Last updated on March 19, 2025

 

Return to Special Authority drug list

Generic name

mometasone furoate-formoterol

Strength & form

mometasone furoate 100 mcg or 200 mcg/formoterol 5 mcg suspension for oral inhalation

Special Authority criteria

Approval period

Diagnosis of asthma

AND

Inadequate response on optimal dose of inhaled corticosteroid

Indefinite

Practitioner exemptions

  • Respirologists and allergists are not required to submit a Special Authority request for coverage

Special Authority request form(s)